Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma.

Sell S, Dunsford HA.

Am J Pathol. 1989 Jun;134(6):1347-63. Review.

2.
3.

Induction of liver tumors in F344 rats by crotonaldehyde.

Chung FL, Tanaka T, Hecht SS.

Cancer Res. 1986 Mar;46(3):1285-9.

4.

Induction of cholangiocarcinoma following treatment of a rhesus monkey with aflatoxin.

Tilak TB.

Food Cosmet Toxicol. 1975 Apr;13(2):247-9. No abstract available.

PMID:
166028
6.

Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?

Sell S.

Environ Health Perspect. 1993 Dec;101 Suppl 5:15-26. Review.

7.

Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies.

Dunsford HA, Karnasuta C, Hunt JM, Sell S.

Cancer Res. 1989 Sep 1;49(17):4894-900.

8.

Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma.

Itoyama M, Hata M, Yamanegi K, Yamada N, Ohyama H, Hirano H, Terada N, Nakasho K.

Med Mol Morphol. 2012 Dec;45(1):7-13. doi: 10.1007/s00795-010-0534-z. Epub 2012 Mar 20.

PMID:
22431178
9.

Enhancement of 2-acetylaminofluorene liver carcinogenesis in rats fed a choline-devoid diet.

Lombardi B, Shinozuka H.

Int J Cancer. 1979 Apr 15;23(4):565-70.

PMID:
220201
10.

Evidence regarding a stem cell origin of hepatocellular carcinoma.

Shupe T, Petersen BE.

Stem Cell Rev. 2005;1(3):261-4. Review.

PMID:
17142863
11.

Cellular events during hepatocarcinogenesis in rats and the question of premalignancy.

Sell S, Hunt JM, Knoll BJ, Dunsford HA.

Adv Cancer Res. 1987;48:37-111. Review.

PMID:
2441577
12.
13.

α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.

Ikeda H, Sato Y, Yoneda N, Harada K, Sasaki M, Kitamura S, Sudo Y, Ooi A, Nakanuma Y.

Hum Pathol. 2012 Nov;43(11):1955-63. doi: 10.1016/j.humpath.2011.11.022. Epub 2012 Apr 17.

PMID:
22516245
14.
15.

Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.

Sasaki M, Matsubara T, Kakuda Y, Sato Y, Nakanuma Y.

Am J Surg Pathol. 2014 Mar;38(3):364-9. doi: 10.1097/PAS.0000000000000125.

PMID:
24487593
17.

Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.

Shibahara J, Hayashi A, Misumi K, Sakamoto Y, Arita J, Hasegawa K, Kokudo N, Fukayama M.

Am J Surg Pathol. 2016 May;40(5):608-16. doi: 10.1097/PAS.0000000000000579.

PMID:
26735856
18.

Liver cancer stem cells.

Sell S, Leffert HL.

J Clin Oncol. 2008 Jun 10;26(17):2800-5. doi: 10.1200/JCO.2007.15.5945. Review. Erratum in: J Clin Oncol. 2008 Aug 1;26(22): 3819.

19.

Induction of cholangiocarcinoma in the Golden Syrian hamster using methylazoxymethyl acetate.

Imray CH, Newbold KM, Davis A, Lavelle-Jones M, Neoptolemos JP.

Eur J Surg Oncol. 1992 Aug;18(4):373-8.

PMID:
1325925
20.

[Thorotrast-related hepatosis].

Martí Vicente A, González Carro P, Enríquez J, Vilardell F.

Rev Esp Enferm Dig. 1993 Jan;83(1):16-9. Spanish.

PMID:
8383989

Supplemental Content

Support Center